Skip to main content
Premium Trial:

Request an Annual Quote

Howard Goldstein

Premium

Howard Goldstein has become senior vice president of sales and marketing, a newly created position, at Seattle-based Amnis.

Most recently, he was senior vice president for sales, service, and marketing at Argonaut Technologies. In the past, he held sales and marketing positions at Incyte Genomics, Molecular Devices, Molecular Dynamics, and Applied Biosystems.

Goldstein received an MBA from Temple University, an MS in biochemistry from the University of Dayton, and a BS in biology from Bucknell University.

In an official company statement dated June 30, Jack Ball, Amnis’ president and CEO, said “having an individual of Howard’s stature and broad experience as a member of the Amnis management team supports moving the company to the next stage and marks our formal transition to full commercial release of the ImageStream 100 system.”

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.